相关实验视频

Updated: May 2, 2026

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

基于等离子体DNA的逆遗传学作为制造蓝舌病疫苗的平台

Tendai A M Mlingo^1,2, Jacques Theron², Nobalanda B Mokoena¹

¹Onderstepoort Biological Products SOC Ltd., Pretoria, South Africa.

Journal of virology

|March 25, 2025

概括

这项研究探索了一种新的基于DNA的逆遗传平台,用于制造蓝舌病病毒 (BTV) 疫苗. 虽然一些合成BTV疫苗在绵羊中表现有前途,但为了稳定性和更广泛的免疫反应,需要进一步优化.

科学领域:

兽医病毒学兽医病毒学
疫苗技术技术疫苗技术
分子生物学分子生物学

背景情况:

蓝舌病 (BT) 控制在很大程度上依赖于疫苗,活衰减疫苗 (LAV) 需要大量的血清型,以在流行地区广泛保护.
目前的LAV制造复杂,需要探索有效的多价值疫苗生产的替代平台.

研究的目的:

评估基于等离子体DNA的逆遗传平台,用于制造多价值蓝舌病病毒 (BTV) 疫苗.
为了比较逆转基因衍生的BTV抗原与商业疫苗的特征,稳定性和免疫性.

主要方法:

通过在BTV1骨干上交换外囊蛋白 (VP2和VP5) 来产生重组BTV血型1,5,6和14的反向遗传平台.
合成抗原的颗粒大小,生长特征,稳定性和保质期与商业疫苗进行了评估.
单价和多价合成疫苗的安全性和免疫性 (中和抗体诱导) 在绵羊中进行了评估.

主要成果:

与商业同行相比,合成BTV1,BTV5和BTV6呈现出明显的增长概况;BTV14的情况类似.
商用疫苗在各种储存条件下表现出卓越的稳定性和保质期.
单价BTV1疫苗是安全的,并诱导了中和抗体 (nAbs). 多价值疫苗诱导BTV6 nAbs,但BTV1反应很弱,BTV5和BTV14没有检测到nAbs.

结论:

基于等离子体DNA的逆遗传学平台显示了开发新型合成BTV疫苗的潜力,在某些血清型中证明了安全性和免疫性.
优化生产产量和稳定性对于某些血清型来说是必要的,以充分实现这个商业BTV疫苗制造平台.
这项研究提供了反向遗传学衍生BTV抗原与商业疫苗的基础比较,推进了替代疫苗生产策略.

关键词:

蓝舌病病毒的感染情况奇摩的奇摩的奇摩的免疫性免疫性免疫性这种病毒是orbivirus.反向遗传学是一种反向遗传学.疫苗疫苗疫苗疫苗

更多相关视频

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

相关概念视频

Viral Mutations

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.